Biliary Tract Cancer near Teaneck, NJ

Care Philosophy: My practice focuses on treating gastrointestinal malignancies, including colorectal, pancreatic, stomach, biliary, neuroendocrine, and liver cancers. I place great value on having strong physician-patient relationships and feel this is especially important in cancer care. I not only provide state-of-the art cancer treatment for my patients and their families, but comprehensive support through a compassionate and multidisciplinary approach. Through clinical research, I am able to offer my patients access to the latest therapies such as radiolabeled monoclonal antibodies, cancer "vaccines," immunotherapy, and other novel targeted agents. At Weill Cornell Medicine and New York-Presbyterian Hospital, we utilize a bench to bedside approach and are committed to bringing the most promising new treatments out of the lab and directly to patients often years before they are widely available elsewhere

Care Philosophy: Pancreatic cancer has been my area of clinical and research focus for the past 15 years. I participated in the process of recognition that outcomes of complex surgery such as that for pancreatic cancer are better in high volume centers when performed by experienced surgeons. In 2006, I conceived, funded and built a multidisciplinary unit with the mission of improving overall outcomes in pancreatic cancer care by integrating the care of multiple medical specialists.

Biography: Dr. Parissa Tabrizian, MD is a General Surgery Specialist who practices in New York, NY. She is 45 years old and has been practicing for 23 years. Dr. Parissa Tabrizian, MD is affiliated with Mount Sinai Hospital.

Care Philosophy: Giving a listening ear to my patients is my most precious source of clinical information.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Care Philosophy: At Moffitt Cancer Center, we are working tirelessly in the areas of patient care, research and education to advance one step further in fighting cancer. As a National Cancer Institute-designated Comprehensive Cancer Center, we are committed to the health and safety of our patients and dedicated to providing expert cancer care. From enhanced quality of life to complete remission, Moffitt is Florida's top choice aiming to achieve the best outcome for each patient.

Biography: Dr. Myron Schwartz, MD is a General Surgery Specialist who practices in New York, NY. He is 72 years old and has been practicing for 49 years. Dr. Myron Schwartz, MD is affiliated with Mount Sinai Hospital.

Care Philosophy: Dr. Shah and the Gastrointestinal Oncology group are committed to providing excellent and personalized care for you and your loved ones. We would welcome the opportunity to take part in your care, whether it involves primary management or for consultation in conjunction with your treating physicians. Ensuring you are receiving the best and most comprehensive treatment for your malignancy is our aim. Please feel free to contact us for an appointment, or have your physician contact us to discuss your care.

Biography: Dr. Daniel Labow, MD is a General Surgery Specialist who practices in New York, NY. He is 57 years old. Dr. Daniel Labow, MD is affiliated with Mount Sinai Brooklyn, Mount Sinai Morningside and Mount Sinai Queens.

Biography: Dr. Celina Ang, MD is a Hematology Specialist who practices in New York, NY. She is 46 years old. Dr. Celina Ang, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Biography: Dr. Peter Kozuch, MD is a Hematology Specialist who practices in New York, NY. He is 57 years old and has been practicing for 31 years. Dr. Peter Kozuch, MD is affiliated with Mount Sinai Hospital, Mount Sinai Morningside and Mount Sinai Queens.

Biography: Paul Chapman, MD is currently the Chief Medical Research Officer for the Meyer Cancer Center at Weill Cornell Medicine and NewYork-Presbyterian Hospital. Dr. Chapman received his M.D. degree from Weill Cornell Medical College in 1981 and trained in internal medicine as an intern and resident at the University of Chicago Hospitals and Clinics from 1981-1984. After that, he returned to New York as a medical oncology Fellow at Memorial Sloan Kettering Cancer where he focused on immunotherapy of melanoma in the laboratory of Dr. Alan Houghton. He joined the faculty of Memorial Sloan Kettering Cancer Center (MSKCC) in 1988 and worked there through 2023 as a tenured Attending Physician. During this time at MSKCC, Dr. Chapman led many clinical and laboratory studies designed to develop new and improved treatments for melanoma. This included the first BRAF targeted therapy trial and several immunotherapy trials. His research continues to focus on developing new treatments for melanoma.